Peptide coupling is a chemical process that leads to the formation of a bond between a component containing a carboxyl group and a component containing an amino group. As a result of this reaction, an amide bond is formed. When such a bond links the amino acid residues during peptide synthesis, it becomes part of what is referred to as the peptide backbone.
Reversible components do not have to be individual amino acids. The binding reaction can combine one amino acid with another, attach another amino acid to the growing peptide chain, or combine larger fragments of peptides that were previously synthesized separately.
At first glance, the assembly of peptides may seem like a simple task: you just need to combine one amino acid with the next.
From a chemical point of view, the formation of an amide bond is, however, only part of the whole goal.
The coupling must occur in the correct place and with the appropriate stereochemical configuration, while other reactive functional groups must remain appropriately controlled. The reaction may appear to proceed successfully and consume most or even all of the starting material, yet lead to the formation of an undesirable mixture of the target peptide and other structures.
Therefore, the completion of the reaction and the correct formation of the product do not mean the same thing.
Studies comparing different binding systems, strategies for protecting functional groups, and stereochemical results show why there is no universally best binding agent, independent of the type of peptide being synthesized.
From a scientific point of view, the more useful question is therefore not:
„Which coupling agent is the best?”
A better question is:
„Which approach allows the intended peptide to be obtained with appropriate conversion, maintaining stereochemical integrity and proper control of impurities under conditions appropriate for the specific molecule?”
This distinction is fundamental to understanding the chemistry of peptide binding.
What does the conjugation of peptides mean?
Joining links two components by creating a new bond
In a typical reaction leading to the formation of a peptide backbone, the carboxyl group attached to one amino acid residue is linked to the amino group of the other residue.
The resulting compound is an amide chemical bond.
If such a bond links the remaining amino acids in the peptide chain, it is commonly referred to as a peptide bond.
The precise physical arrangement of the reacting components depends on the synthesis strategy employed.
During peptide synthesis at the solid phase, the exposed amino group usually belongs to the growing peptide chain attached to the resin, whereas the component containing the carboxyl group comes from the introduced protected amino acid.
In the synthesis carried out in solution, both components can, however, be in the liquid phase.
In the case of joining fragments, larger, protected peptide segments are combined, instead of adding individual amino acid residues one after another.
Different strategies change the way reactions are conducted, the separation of materials and their purification, but they do not eliminate the fundamental chemical problem: the appropriate functional groups must react with each other, while the undesirable reactions in other parts of the molecule should remain appropriately limited.
Bonding, conversion, and yield are different concepts
Several terms often used when describing the binding of peptides may sound similar, even though they refer to different topics.
Conversion determines what part of the given starting material has undergone a reaction.
However, it does not automatically tell us what this material has been transformed into.
If 99% of the starting material is lost, but some of it forms unwanted byproducts, 99 percent conversion does not mean that 99% intended peptides were formed.
The formation of the target product answers another question: how much of the intended molecular structure has actually been formed? The answer requires an analytical method that allows distinguishing the correct product from important alternative structures.
Isolated yield describes the amount of a specific product that was ultimately recovered relative to the defined amount of starting material. Therefore, the final yield may also be influenced by processing, separation, and purification steps, even if the actual coupling itself was efficient.
Chromatographic purity describes the distribution of the components detected under the conditions of a specific chromatographic method. It can provide very valuable information about the composition of the sample, but its interpretation may be limited by coelution, differences in the detector response, or the presence of components poorly detected by the given method.
Stereochemical purity, on the other hand, answers the question of whether the intended spatial configuration of the molecule has been preserved. This is a separate analytical issue, because some stereochemical variants can have exactly the same molecular mass as the target product.
These differences help to understand the results that at first glance may seem contradictory.
The reaction can exhibit high conversion of the starting material while simultaneously producing several products. The crude product may have a high recovered mass but contain a significant amount of impurities. Intensive purification, however, can lead to obtaining material of high purity at the expense of lower yield of the isolated product.
None of these observations is in itself contradictory to the others.
They simply describe the different properties of the product or the different stages of the process.
Therefore, the statement „the measurement was complete” has much greater value if it is also known which analytical method was used and what exactly was measured.
Difficult substrates reveal various limitations of the process
Not every peptide binding reaction involves the same degree of chemical complexity.
A sterically crowded reactive site can slow down the bond formation because the reacting groups have restricted access to each other.
Poor solubility can limit the effective contact between the reaction components.
In a solid-phase synthesis, a growing peptide chain can interact with neighboring chains or take on structures that restrict access to reactive sites, even if coupling reagents are present in an apparent excess.
These problems have different chemical origins.
Therefore, one cannot assume that one solution will automatically be effective in all cases.
Studies comparing repeated coupling strategies for difficult peptide sequences analyzed the actual composition of the resulting crude products, rather than relying solely on the theoretical reactivity or reputation of the individual reagents. One of the studied strategies performed well in the analyzed models, but this does not mean that there is a universal solution suitable for every peptide sequence.
The most important conclusion is that the effectiveness of the method should be evaluated based on the product obtained from a specific substrate, and not solely based on the reputation of the reagent used.
Activation of the carboxyl group
Why is activation usually necessary?
The mere mixing of unmodified carboxylic acid with an amine under normal conditions usually does not efficiently lead to the formation of pure peptide bond.
Instead, acid–base interactions can occur, and the effective formation of the amide bond requires an appropriate chemical pathway.
Therefore, the binding of peptides usually involves the activation of a component containing a carboxyl group.
Activation increases its susceptibility to reaction with the appropriate amino group. The appropriate reaction environment and the appropriate leaving group facilitate the formation of a new amide bond.
An activated intermediate product can only exist for a short time and does not have to be isolated.
However, the goal is not to achieve the maximum possible chemical reactivity.
The goal is controlled reactivity.
An activated intermediate product that reacts very quickly with water, with another undesirable nucleophile, or that participates in a competitive reaction can quickly disappear while simultaneously leading to the formation of a relatively small amount of the intended peptide.
High reactivity is therefore only beneficial when it can be appropriately directed towards the formation of the intended bond.
Coupling agents and additives perform different functions
Several types of chemical components that perform different functions can participate in the assembly of peptides.
Carbodiimides are one of the families of reagents used to activate carboxyl groups.
Other coupling systems use different activation mechanisms, including the often encountered ion-type reactions, such as systems based on HATU.
Additional compounds can serve as additives.
The term „additive” does not, however, mean that the given compound is chemically insignificant. An additive can affect intermediate products, coupling efficiency, competing reaction pathways, and stereochemical outcomes.
Studies on Oxyma in the synthesis of peptides involving carbodiimides analyzed both the efficiency of binding and the reduction of racemization in selected models.
Such data are valuable for the studied systems and specific models.
However, this does not mean that using the same compound in every possible peptide pairing will yield the same result.
Later Oxyma-B studies compared the results regarding optical purity in several model peptides.
The study of many substrates is particularly important because very good results in facile chemical coupling do not necessarily predict the behavior of the reagent in a sterically crowded, aggregation-prone or stereochemically sensitive site.
What does HATU mean in peptide synthesis?
HATU is a coupling reagent used to facilitate the formation of amide bonds, including during the synthesis of peptides.
HATU is not a peptide.
It is also not a security group.
Its presence alone does not prove that the conjugation has been completed or that the peptide obtained is pure.
Efficiency depends on the type of substrate, the other reactants, the solvent system, and the broader context of the reaction conditions.
The studies of the sequences susceptible to aggregation compared, among other things, approaches based on HATU and Oxyma/carbodiimide systems under repeated binding conditions.
This shows why searches such as „HATU peptide” should be understood as questions about the chemistry of coupling and the choice of method, rather than as evidence that one specific reagent constitutes a universal method for peptide synthesis.
The very name of the reagent is not sufficient to reproduce or properly interpret the published result.
The reaction conditions, the peptide sequence, and the analytical method for defining the success of the process are also important.
Activation and stereochemical control require maintaining balance
Prolonged retention of the activated amino acid derivative in the reaction system is not always beneficial.
The desired coupling reaction occurs alongside other possible chemical processes.
Some competitive routes can change the stereotype.
Experimental studies on protected epimeric products analyzed the effect of combinations of amino acids, solvent, and other reaction components on the stereochemical changes occurring during coupling involving carbodiimides.
This illustrates an important principle: the entire reaction environment can be as important as the overall family of coupling reagents used.
The coupling strategy must therefore provide sufficient reactivity to form the desired bond, while limiting the possibility of undesirable reactions occurring.
These principles can be discussed for educational purposes without converting them into a ready-made laboratory protocol. The exact amounts of reagents, the order in which they are added, and the reaction conditions depend on the specific synthesis process being developed.
The role of security groups
Security restricts the number of reaction spots available
An amino acid can contain more reactive groups than just the amino and carboxyl groups needed to form the peptide backbone.
Its side chain may contain additional reactive chemical groups.
If all potentially reactive groups remained exposed during each step of the coupling, the intended peptide bond formation could compete with branching or other undesirable reactions.
The strategy of using protective groups temporarily allows for masking selected reactive sites.
This allows appropriate amino and carboxyl groups to react with each other, while other sites remain inaccessible or sufficiently inactive under the given conditions.
Security therefore provides chemical selectivity.
An effective strategy, however, does not solely consist of attaching a chemically stable group.
The security group also needs to be removed later.
The protection, which effectively prevents unwanted reactions during coupling, but cannot be removed later without damaging the target molecule, creates another synthetic problem.
A full strategy must therefore take into account both the stability during the period when protection is needed and the possibility of selectively removing the protection when it no longer is needed.
Temporary and long-term safeguards perform different functions
Individual protective groups may remain on the particle for different periods of time.
In a typical synthesis at the fixed phase using Fmoc protection of the final amino group of the growing chain is repeatedly removed as the sequence is extended.
Many groups of side chain proteases remain present for numerous cycles of binding, however, and are only removed at a later stage.
Standard methods based on Fmoc show how the repeated cycles of selective removal of the protecting groups and coupling are coordinated.
The type of protection required for a particular side chain depends on the rest of the amino acid, the entire peptide, and the chosen synthesis strategy.
It would therefore not be correct to state that each amino acid requires identical protection or that all syntheses use the same protective groups.
Temporary protective groups should also be distinguished from chemical groups that remain intentionally present in the ready-made peptide.
The planned modification of the N-terminus or the amide at the C-terminus can, for example, be an element of the target structure.
However, a temporary protective group that accidentally remained in the final molecule would represent an undesirable structural difference.
Orthogonality is a requirement for chemical compatibility
Orthogonal protection means a strategy in which selected protective groups can be removed, leaving other safeguards sufficiently intact.
This allows revealing various reactive sites at deliberately selected stages of the synthesis.
Orthogonality should not be understood simply as the property of a single reagent as written on its label.
It describes the compliance of the entire planned sequence of chemical operations.
The intended removal of the protective cap should occur without causing unacceptable changes in other parts of the growing peptide.
In solid-phase synthesis, this compatibility can also include the carrier–linker system and unconventional or particularly chemically sensitive building blocks.
Studies on the formation of aspartimid, in which the side chain and backbone protection were modified in a model peptide, showed differences in the formation of side products.
This shows that the choice of protection can affect not only the occurrence of the obvious side chain reaction.
It can also change other pathways for the formation of pollutants during synthesis.
Protective groups do not cause all sequences to behave the same way.
Even if two sequences contain the same potentially problematic amino acid, they do not have to behave identically.
The neighboring residues may influence the probability of the occurrence of competing reactions.
Systematic studies of model sequences containing aspartic acid showed that the amino acid following this residue influenced the formation of aspartimid-related products under the tested conditions.
This does not mean that every sequence containing such a motif must cause problems.
It does, however, show that the context of the sequence should be taken into account when developing the method and assessing the risk.
The stabilization strategy that worked in one model peptide does not guarantee identical behavior for every other peptide containing the same residue.
Racism and other side effects
Racemization and epimerization refer to the spatial arrangement of the molecule
Many amino acid residues contain a stereogenic center.
Changing the configuration of such a center can lead to the formation of a structurally different molecule, even if its elemental composition and molecular mass remain unchanged.
Strictly speaking, racemization means the loss of enantiomeric enrichment towards a racemic mixture.
In a peptide containing many stereogenic centers, the inversion of the configuration of one specific center usually leads to the formation of an epimer, that is, a type of diastereoisomer.
However, in the literature on peptide synthesis, the term „racemization” is often used more broadly to refer to undesirable changes in the configuration that occur during binding or other stages of synthesis.
This distinction is important because the identity of a peptide does not depend solely on which atoms are present in the molecule.
Their spatial arrangement also matters.
Not every amino acid residue is associated with the same stereochemical risk.
Glycine, for example, does not have the typical chiral alpha carbon atom present in most amino acids.
The remaining residues differ in their susceptibility to changes in the configuration depending on their structure and reaction environment.
Normal mass may be accompanied by incorrect stereochemistry
The epimeric peptide can have exactly the same molecular mass as the target peptide.
Therefore, observing the expected mass using mass spectrometry does not automatically prove that every amino acid residue has retained the intended stereochemical configuration.
Chromatographic studies allowed the separation of protected epimeric peptides and the use of these separations for the analysis of stereochemical changes associated with the coupling chemistry.
Depending on the molecule, appropriate stereochemical evaluation may require appropriate chromatographic methods, reference compounds, derivatization strategies, or other analytical methods capable of distinguishing between relevant structures.
Individual analytical studies also analyzed the stereochemical changes occurring during the attachment of amino acids to solid carriers.
This leads to another important conclusion: the contamination detected in the ready-made peptide does not have to come from the last coupling reaction.
It could have arisen at an earlier stage and remained present during the subsequent stages of synthesis.
The formation of aspartimide is a separate problem.
The formation of aspartimid is a specific pathway of side reaction associated with susceptible peptide sequences containing aspartic acid.
The process involves the creation of a cyclical intermediate product from which various related structures can subsequently be formed.
They can include altered peptide backbone connections and stereochemical variants.
The formation of aspartimide should therefore not be described simply as another name for incomplete coupling.
The peptide chain may already contain the appropriate amino acid residues, and a subsequent side reaction may modify part of its structure.
Experimental studies show that the protection strategy, adjacent residues, and recurring conditions associated with the removal of protective groups can all influence this process.
This distinction is particularly important when interpreting problems encountered in synthesis.
Simply repeating the coupling or adding more coupling reagent will not automatically repair the contamination that occurred as a result of a completely different chemical pathway.
Incomplete reactions lead to other kinds of problems
Incomplete coupling creates a separate category of pollutants.
If one chain of the protein is not supplied with the intended amino acid but reacts properly during a later cycle, the resulting peptide may be devoid of that residue.
Such a molecule is usually referred to as a deletion sequence.
Other chains may stop growing and remain shortened.
These products are fundamentally different from epimers.
An epimer can have a correct amino acid sequence and a sumary pattern, but an incorrect stereochemistry at one center.
A degenerate peptide, on the other hand, has a different sequence or length.
Some synthesis strategies use so-called capping to prevent further extension of specific unreacted chains.
However, capping does not repair the defective chain and does not convert it into the target peptide.
It only changes its behavior during the subsequent stages.
The crude mixture obtained during synthesis can therefore contain products formed as a result of several different mechanisms.
The aggregate value of performance does not allow determining which mechanisms of pollutant formation were responsible for the final result.
Temperature and process conditions influence the trade-off between speed and quality
Increasing the temperature or other methods of accelerating the synthesis can increase the speed of the desired reactions.
At the same time, they can, however, accelerate the adverse reactions.
Studies using SPPS assisted microwave analysis examined racemization and the formation of aspartimid in model systems and demonstrated a species-dependent sensitivity in the applied conditions.
This does not mean that heating is inherently inappropriate in the synthesis of peptides.
It also does not mean that a lower temperature is always better.
The most important principle is: the speed of the process and the chemical quality must be evaluated simultaneously.
Higher temperatures, longer exposure times, or repeated processing can both affect the desired formation of bonds and competitive reactions.
An appropriate compromise should therefore be evaluated experimentally for a specific sequence.
Modifications to the final product can also occur after the actual assembly has been completed.
Studies comparing different scavengers during the depeptide extraction from the resin showed different contaminant profiles.
This suggests that final contamination should not be automatically attributed to the coupling reaction.
The synthesis of a peptide is a multistep process, and subsequent deprotection, dephosphorylation, and further processing can alter the material that was previously built correctly.
How is the effectiveness of the coupling assessed?
The tests performed during the process only answer specific questions.
During the steady-state synthesis, a test for the remaining available amino groups can help assess whether the acylation step may have been incomplete.
Such tests can be very useful.
Their interpretation should, however, be limited to the chemical question for which the method used actually provides an answer.
Depending on the analytical method and the type of amino acid, color-change-based tests may react differently to different amines.
The availability of the tested area also matters.
A reactive amino group to which the test reagent has physically restricted access is not the same as an amino group that has successfully undergone the coupling reaction — even if the test is unable to unequivocally distinguish between these two situations.
Therefore, limitations may include the availability of the reactive site, the sensitivity of the test, chemical interference, and the type of functional group detected.
The negative result of a test conducted during the process should not be automatically interpreted as evidence that the entire peptide has the correct sequence, stereochemistry, and purity.
Monitoring the process is most valuable when the results can be later compared with the analysis of the actual peptide product.
Chromatography separates, and mass spectrometry helps characterize the components.
Chromatography and mass spectrometry provide complementary information.
Chromatography can separate the components of a sample and show the presence of more than one detectable component.
Mass spectrometry can provide information about the molecular mass, helping to characterize or assign individual components.
Studies combining both techniques allowed the analysis of crude products of peptide synthesis at the solid phase and the obtaining of information regarding their identity and the degree of removal of protective groups.
The combination of both methods usually provides more information than the assumption that each chromatographic peak has already been identified or that each detected mass corresponds to a pure and structurally complete fraction.
However, there are still limitations.
Different components can coexist, that is, they cannot be completely separated by chromatography.
Individual substances can also cause a different response from the detector.
Structural isomers and stereoisomers may require the use of additional analytical methods.
For the same reason, the mere statement that a peptide has been tested using the HPLC method does not automatically mean that all relevant impurities have been resolved.
The usefulness of a specific HPLC method depends on the actual yield obtained and on the analytical question it is intended to answer.
It should be explained how the result was calculated
The percentage value given in relation to the binding of peptides can mean several completely different things.
It may refer to the conversion of the starting material, the relative surface area of the chromatographic peak, the measured content of the target product, the yield of the crude product, or the yield of the isolated product.
Providing the number itself without explaining what it refers to can therefore create the misleading impression of great precision.
Reliable comparisons should specify the substrate, the analyzed coupling step, the analytical method used, the moment of sample collection, and the types of pollutants being analyzed.
If repeated pairing has been used, this should also be taken into account.
The final result after two coupling operations does not necessarily reflect what happened during the first reaction.
Similar caution is required regarding the limits of the detectability of analytical methods.
The statement „not detected” means that the substance was not detected under the specified conditions and within the limitations of the method used.
It should not be automatically assumed that the data pollution does not exist at all.
Data regarding the reagent should include more than a simple model.
The coupling agent, which works exceptionally well in the simple model reaction, may behave differently in the case of an amino acid with a high steric crowding, a sensitive stereochemical center, a poorly soluble substrate, or a peptide chain susceptible to aggregation.
Studies comparing Oxyma-B in several model peptides show why assessing binding chemistry on more than one substrate is valuable.
Ultimately, a useful coupling method should lead to the desired structure with an acceptable impurity profile and a repeatable result for the target synthesis.
Therefore, the effectiveness of coupling can be better understood as a collection of different measurements than as a property described by the name of a single reagent or the result of a single substrate depletion test.
Frequently asked questions
1. Why do peptide syntheses require protecting groups?
Protective groups temporarily limit undesirable reactions, allowing appropriate functional groups to form the intended peptide bond. Amino acids can contain several reactive sites, and leaving all of them available simultaneously can lead to competing reactions. An effective protection strategy must also take into account the possibility of later removal of the protections and their compatibility with the rest of the molecule. Model studies show that the choice of protective groups can affect not only the basic selectivity of the reaction but also the formation of side products. A protective group is therefore one element of the entire synthesis strategy, rather than a universal solution to all chemical problems.
2. Can the correct coupling still lead to the formation of impurities?
Yes. Intentional peptide binding can occur while other molecules in the same mixture undergo incomplete conversion or undesirable side reactions. This is particularly well demonstrated with epimeric products, since the formation of the correct binding and the preservation of the correct stereochemistry are separate processes. The detection of the target peptide does not therefore mean that it is the only product present. A scientifically justified assessment of the success of the binding requires a defined endpoint for the analysis and information regarding relevant impurities.
3. Is the coupling of peptides the same as the entire peptide synthesis?
No. Coupling is a single operation of creating a bond within a much broader synthesis process. Synthesis at the solid phase may also include attachment to a carrier, protection, removal of protective groups, multiple washing, deprotection, processing, purification, and final characterization. Since undesirable products can also form outside the coupling step, final contamination should not be automatically attributed to improper coupling without data indicating its actual origin.
4. Why is the carboxyl group activated?
The activation of the carboxyl group creates a more favorable pathway for its reaction with the appropriate amino group, thus facilitating the formation of an amide bond. However, the increased reactivity may also allow for competitive reactions. Therefore, when evaluating coupling systems, one considers not only the efficiency of the formation of the bond but also the stereochemical effects and the formation of side products. The goal of activation is not to maximize the reactivity of the molecule but to achieve appropriate selectivity of the reaction.
5. What is the purpose of HATU?
HATU is a coupling agent used to facilitate the formation of amide bonds, including during the coupling of peptides. It is not a peptide nor a protective group. Comparative studies of difficult peptide sequences show that methods using HATU should be evaluated in the full context of the reaction conditions. The mere fact that HATU was used does not confirm complete conversion, stereochemical retention, or improved impurity profile.
6. Is there one best reagent for peptide coupling?
No. There is no universal ranking of reagents suitable for every peptide and reaction. Stacking, substrate solubility, aggregation, stereochemical sensitivity, and sequence context can all influence the result. The choice of reagent should therefore be based on measured results for a specific reaction, and not solely on its reputation or popularity.
7. Do the terms „coupling agent” and „additive” mean the same thing?
No. These terms can describe different functions in the coupling system. The coupling reagent can directly participate in the activation, while the additive can influence the formation of intermediate products, the efficiency of the reaction, stereochemical integrity, or competing chemical pathways. Therefore, the entire reaction system should be analyzed, and not all its components should be treated as interchangeable equivalents.
8. Is it possible to combine entire fragments of peptides instead of individual amino acids?
Yes. The ligation reaction can combine larger, protected peptide fragments rather than just individual amino acids. However, increasing the size of the reacting components does not eliminate the need to control the selectivity of the reaction site, stereochemistry, or the final product characteristics. For fragment ligation, data still need to be provided to confirm that the correct combination has indeed been formed properly.
9. What is the difference between racemization and epimerization?
Racemization in the strict sense means the loss of enantiomeric enrichment towards a racemic mixture, whereas epimerization means a change in the configuration of one stereogenic center in a molecule containing many such centers. In the literature on peptide synthesis, the term racemization is often used more broadly to describe undesirable changes in the configuration of the amino acid residues. Therefore, a precise definition should correspond to the actual structural change.
10. Can mass spectrometry detect any stereochemical error?
No. Stereoisomers can have exactly the same molecular mass. Obtaining the expected mass therefore does not confirm the correct configuration of each stereogenic center. Additional methods may be needed to assess such differences, such as appropriate chromatographic techniques or derivatization strategies. Mass spectrometry remains an extremely useful tool for molecular characterization, but its results should be interpreted in accordance with the limitations of the specific structural question.
11. Does the formation of aspartimid simply mean unsuccessful binding?
No. The formation of aspartimid is a separate side reaction pathway associated with susceptible sequences containing aspartic acid. Its occurrence can be influenced by neighboring residues and conditions related to the removal of protective groups. Therefore, an undesirable structural change can occur even when the appropriate amino acid has been properly joined earlier. Determining the origin of the contamination is important because repeating the binding does not necessarily solve the problem arising from a completely different reaction pathway.
12. Does repeating the coupling guarantee the success of the reaction?
No. Re-coupling can improve conversion in some cases, but it does not guarantee that all reactive sites will become available or that other side effects will be eliminated. The result still depends on the substrate and the method used. Therefore, product analysis is necessary to determine what actually gave rise to the additional coupling.
13. Does higher temperature always improve the quality of mating?
No. Increasing the temperature can speed up the desired reaction, but it can also accelerate undesirable chemical processes. Therefore, faster conversion should not be automatically interpreted as an improvement in chemical quality. The temperature must be evaluated both in terms of the formation of the target product and the profile of the resulting impurities.
14. Does the disappearance of the free amino group confirm the formation of a proper peptide?
No. The absence of a detectable free amino group answers a much narrower question regarding a specific functional group under the conditions of the test used. It does not independently confirm the complete peptide sequence, its stereochemistry, or purity. Monitoring free amino groups can be a useful element of process control, but it does not replace the final product characterization.
15. Is the purity of HPLC the same as the binding efficiency?
No. HPLC purity and yield describe different properties. HPLC purity is dependent on the method used to describe the composition of the sample components being detected, while yield refers to the quantity of a specific product obtained relative to the defined amount of starting material. Purification can increase chromatographic purity while simultaneously reducing the amount of recovered target product. Therefore, the percentage value is of limited significance unless exactly stated what it represents.
16. Can contamination occur even after the coupling has been completed?
Yes. After the binding reaction is complete, peptide synthesis involves further chemical steps. Removal of protective groups, deprotection, and further processing can modify the molecule or lead to the formation of additional impurities. This does not mean that each final impurity is created in later stages, but it does show why proper binding is not a guarantee of the quality of the final product.
17. What makes the comparison of coupling methods reliable?
A reliable comparison should assess alternative methods for the same clearly defined goal and under sufficiently comparable conditions. It should indicate the substrates used, the sampling stage, analytical methods, and the types of contaminants evaluated, rather than presenting an unexplained percentage value or relying on the reputation of the reagent. Comparisons involving several different model peptides can provide more information than a single high yield obtained for a simple substrate, because they show how the effectiveness changes with the molecular context. Even then, conclusions should remain limited to the actually tested chemical systems.
Summary
Peptide binding is a fundamental element of chemical peptide synthesis, because it leads to the formation of amide bonds that link the amino acid residues in the peptide backbone. However, describing binding solely as „the joining of two amino acids” overlooks a significant portion of the chemistry that determines whether the resulting product is indeed the intended peptide.
A component containing a carboxyl group usually requires activation to allow the effective formation of an amide bond to occur properly. Coupling agents and additives can facilitate this process, but their effectiveness depends on the substrate, the reaction environment, and the method of analytical evaluation of the result. Therefore, the reagent must be analyzed in its full experimental context and not classified independently of the synthesized peptide.
Protective groups provide an additional level of control by temporarily preventing unwanted functional groups from participating in the reaction. Their usefulness depends not only on effective protection, but also on the ability to selectively remove and conform to subsequent synthesis steps. The protection strategy and the adjacent amino acid residues can also influence the formation of specific side products.
Stereochemical integrity is another important element. The coupling reaction can lead to the formation of an amide bond while simultaneously generating an epimeric material. Since the epimer can have the same molecular mass as the corresponding peptide, the mass similarity alone does not confirm the full structural correctness. Changes in configuration can also occur at other stages, such as the initial attachment of the amino acid to the solid phase.
Other impurities are formed through different mechanisms. Incomplete binding can lead to the formation of deletion or truncated sequences, while reactions involving aspartimidine can modify a peptide already containing the appropriate amino acid residues. The acceleration of the process can affect both desired reactions and by-products, and additional impurities can also form during later stages, such as cleavage.
For these reasons, the evaluation of peptide binding requires more than just determining whether the starting material has disappeared.
Conversion, the formation of the target product, isolated yield, chromatographic purity and stereochemical purity answer various questions.
Tests performed during synthesis can help detect incomplete reactions, but they do not independently confirm the complete structure of a peptide. Chromatography and mass spectrometry provide complementary information, while questions regarding stereochemistry or very similar structures may require additional analytical methods.
The most justified approach to peptide docking is therefore targeted at a specific molecule and based on data.
The useful coupling method is not simply a method that uses the most known or most reactive reagent. It is a method that, in a repeatable manner, leads to the formation of the intended molecular bond while maintaining appropriate stereochemical integrity and control of relevant impurities for the specific peptide being synthesized.
References
- Subirós-Funosas, R., Prohens, R., Barbas, R., El-Faham, A., & Albericio, F. (2009). Oxyma: An efficient additive for peptide synthesis to replace the benzotriazole-based HOBt and HOAt with a lower risk of explosion. Chemistry—A European Journal, 15(37), 9394–9403. https://doi.org/10.1002/chem.200900614
- Miyazawa, T., Otomatsu, T., Yamada, T., & Kuwata, S. (1992). Studies of racemization in peptide synthesis through the separation of protected epimeric peptides by reversed-phase high performance liquid chromatography. International Journal of Peptide and Protein Research, 39(3), 229–236. https://doi.org/10.1111/j.1399-3011.1992.tb00794.x
- Caporale, A., Doti, N., Sandomenico, A., & Ruvo, M. (2017). Evaluation of combined use of Oxyma and HATU in aggregating peptide sequences. Journal of Peptide Science, 23(4), 272–281. https://doi.org/10.1002/psc.2977
- Jad, Y. E., Khattab, S. N., de la Torre, B. G., Govender, T., Kruger, H. G., El-Faham, A., & Albericio, F. (2014). Oxyma-B, an excellent racemization suppressor for peptide synthesis. Organic & Biomolecular Chemistry, 12(42), 8379–8385. https://doi.org/10.1039/c4ob01612b
- Coin, I., Beyermann, M., & Bienert, M. (2007). Solid-phase peptide synthesis: From standard procedures to the synthesis of difficult sequences. Nature Protocols, 2(12), 3247–3256. https://doi.org/10.1038/nprot.2007.454
- Mergler, M., Dick, F., Sax, B., Weiler, P., & Vorherr, T. (2003). The aspartimide problem in Fmoc-based SPPS. Part I. Journal of Peptide Science, 9(1), 36–46. https://doi.org/10.1002/psc.430
- Mergler, M., Dick, F., Sax, B., Stähelin, C., & Vorherr, T. (2003). The aspartimide problem in Fmoc-based SPPS. Part II. Journal of Peptide Science, 9(8), 518–526. https://doi.org/10.1002/psc.473
- Adamson, J. G., Hoang, T., Crivici, A., & Lajoie, G. A. (1992). Use of Marfey’s reagent to quantitate racemization upon anchoring of amino acids to solid supports for peptide synthesis. Analytical Biochemistry, 202(1), 210–214. https://doi.org/10.1016/0003-2697%2892%2990229-z
- Palasek, S. A., Cox, Z. J., & Collins, J. M. (2007). Limiting racemization and aspartimide formation in microwave-enhanced Fmoc solid phase peptide synthesis. Journal of Peptide Science, 13(3), 143–148. https://doi.org/10.1002/psc.804
- Pawlas, J., Svensson, T., & Rasmussen, J. H. (2019). 1,4-Benzenedimethanethiol (1,4-BDMT) as a scavenger for greener peptide resin cleavages. RSC Advances, 9(67), 38928–38934. https://doi.org/10.1039/c9ra08553j
- McKellop, K., Davidson, W., Hansen, G., Freeman, D., & Pallai, P. (1991). The characterization of crude products from solid-phase peptide synthesis by mu-HPLC/fast atom bombardment mass spectrometry. Peptide Research, 4(1), 40–46. PubMed